Literature DB >> 7748032

Intensive surveillance of femoropopliteal-tibial autogenous vein bypasses improves long-term graft patency and limb salvage.

T M Bergamini1, S M George, H T Massey, P K Henke, T W Klamer, G E Lambert, F B Miller, R N Garrison, J D Richardson.   

Abstract

OBJECTIVE: The authors determined the impact of an intensive surveillance program of autogenous vein bypasses on patency and limb salvage. SUMMARY BACKGROUND DATA: Surveillance protocols of vein bypasses can identify graft-threatening lesions to permit elective revisions before thrombosis. The authors compared follow-up based on clinically indicated procedures with intensive surveillance.
METHODS: From 1985 to 1994, 615 autogenous vein bypasses (454 in situ, 161 reversed/composite) to popliteal (n = 169) and tibial (n = 446) arteries were performed for critical limb ischemia (n = 507), claudication (n = 88), and popliteal aneurysm (n = 20). Intensive surveillance of autogenous vein bypasses consisted of ankle brachial index and duplex scan with graft velocities measured at 1 month, 3 months, 6 months, and every 6 months subsequently. After surgery 317 bypasses had intensive surveillance, 222 bypasses were clinically indicated for follow-up, and 76 bypasses were excluded because follow-up or patency was less than 31 days.
RESULTS: Primary patency at 5 years was similar for bypasses treated by intensive surveillance (56%) and those treated with clinically indicated procedures (67%). Secondary patency and limb salvage at 5 years was significantly improved (p < 0.02) for bypasses followed by intensive surveillance (80% and 94%) compared with clinically indicated procedures (67% and 73%). Revision of patent bypasses was higher (p < 0.000001) for bypasses treated by intensive surveillance (61 of 70, 87%) compared with those treated with clinically indicated procedures (9 of 34, 26%). Secondary patency at 2 years was significantly higher (p < 0.02) for revision of patent bypasses (79%) compared with thrombosed bypasses (55%).
CONCLUSIONS: Long-term autogenous vein bypass patency and limb salvage is significantly improved by intensive surveillance, permitting identification and correction of graft threatening lesions before thrombosis.

Entities:  

Mesh:

Year:  1995        PMID: 7748032      PMCID: PMC1234628          DOI: 10.1097/00000658-199505000-00008

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  24 in total

1.  Monitoring functional patency of in situ saphenous vein bypasses: the impact of a surveillance protocol and elective revision.

Authors:  D F Bandyk; D D Schmitt; G R Seabrook; M B Adams; J B Towne
Journal:  J Vasc Surg       Date:  1989-02       Impact factor: 4.268

2.  Suggested standards for reports dealing with lower extremity ischemia. Prepared by the Ad Hoc Committee on Reporting Standards, Society for Vascular Surgery/North American Chapter, International Society for Cardiovascular Surgery.

Authors: 
Journal:  J Vasc Surg       Date:  1986-07       Impact factor: 4.268

3.  Biologic fate of autogenous vein implants as arterial substitutes: clinical, angiographic and histopathologic observations in femoro-popliteal operations for atherosclerosis.

Authors:  D E Szilagyi; J P Elliott; J H Hageman; R F Smith; C A Dall'olmo
Journal:  Ann Surg       Date:  1973-09       Impact factor: 12.969

4.  Improved patency in reversed femoral-infrapopliteal autogenous vein grafts by early detection and treatment of the failing graft.

Authors:  H D Berkowitz; S M Greenstein
Journal:  J Vasc Surg       Date:  1987-05       Impact factor: 4.268

5.  A low flow velocity predicts failure of femoropopliteal and femorotibial bypass grafts.

Authors:  D F Bandyk; R F Cato; J B Towne
Journal:  Surgery       Date:  1985-10       Impact factor: 3.982

6.  Value of routine vascular laboratory studies to identify vein graft stenosis.

Authors:  H D Berkowitz; C L Hobbs; B Roberts; D Freiman; J Oleaga; E Ring
Journal:  Surgery       Date:  1981-12       Impact factor: 3.982

7.  Vein graft stenosis. Characteristics and effect of treatment.

Authors:  J G Sladen; J L Gilmour
Journal:  Am J Surg       Date:  1981-05       Impact factor: 2.565

8.  Serial noninvasive studies do not herald postoperative failure of femoropopliteal or femorotibial bypass grafts.

Authors:  R W Barnes; B W Thompson; C M MacDonald; M L Nix; A Lambeth; A D Nix; D W Johnson; B H Wallace
Journal:  Ann Surg       Date:  1989-10       Impact factor: 12.969

9.  Impact of a color-flow duplex surveillance program on infrainguinal vein graft patency: a five-year experience.

Authors:  M M Idu; J D Blankenstein; P de Gier; E Truyen; J Buth
Journal:  J Vasc Surg       Date:  1993-01       Impact factor: 4.268

10.  Recognition and management of impending vein-graft failure. Importance for long-term patency.

Authors:  J R Cohen; J A Mannick; N P Couch; A D Whittemore
Journal:  Arch Surg       Date:  1986-07
View more
  3 in total

1.  Peripheral arterial disease: Epidemiology, natural history, diagnosis and treatment.

Authors:  Gurbir Dhaliwal; Debabrata Mukherjee
Journal:  Int J Angiol       Date:  2007

2.  Critical assessment of the outcome of infrainguinal vein bypass.

Authors:  J Golledge; J Iannos; J A Walsh; J R Burnett; R K Foreman
Journal:  Ann Surg       Date:  2001-11       Impact factor: 12.969

3.  Tension-Free Management of Surgical Wound in Paramalleolar Bypass.

Authors:  Yoshihiko Tsuji; Ikuro Kitano; Yoriko Tsuji
Journal:  Ann Vasc Dis       Date:  2020-09-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.